Expression of LL-37 by Human Gastric Epithelial Cells as a Potential Host Defense Mechanism Against Helicobacter pylori

Kouji Hase, Masamoto Murakami, Mitsutoshi Iimura, Sheri P. Cole, Yoshimune Horibe, Takaaki Ohtake, Marygorret Obonyo, Richard L. Gallo, Lars Eckmann, Martin F. Kagnoff

Research output: Contribution to journalArticle

157 Citations (Scopus)

Abstract

Background & Aims: LL-37/human cationic antimicrobial peptide 18 (hCAP18) is a human cathelicidin with broad-spectrum antimicrobial, lipopolysaccharide binding, and chemotactic activities. This study examined the role of LL-37/hCAP18 in gastric innate immune defense by characterizing its constitutive and regulated expression by human gastric mucosa and its bactericidal activity against the gastric pathogen Helicobacter pylori. Methods: LL-37/hCAP18 messenger RNA expression in normal and H. pylori-infected gastric mucosa and gastric epithelial cells was determined by in situ hybridization, real-time polymerase chain reaction, immunostaining, and immunoblot analysis. Bactericidal activity was measured by using a colony-forming unit assay. Results: LL-37/hCAP18 messenger RNA and protein were expressed in a distinct distribution by surface epithelial cells as well as chief and parietal cells in the fundic glands of normal gastric mucosa. LL-37/hCAP18 was significantly increased in the epithelium and gastric secretions of H. pylori-infected patients, but not in individuals with non-H. pylori-induced gastric inflammation. Infection of cultured gastric epithelial cells with a wild-type but not an isogenic ΔcagE mutant strain of H. pylori increased LL-37/hCAP18 expression, indicating that H. pylori-induced regulation of LL-37/hCAP18 production required an intact type IV secretion system. LL-37, the C-terminal peptide of LL-37/hCAP18, alone or in synergy with human β-defensin 1, was bactericidal for several H. pylori strains. Conclusions: These data indicate that H. pylori up-regulates production of LL-37/hCAP18 by gastric epithelium and suggest this cathelicidin contributes to determining the balance between host mucosal defense and H. pylori survival mechanisms that govern chronic infection with this gastric pathogen.

Original languageEnglish
Pages (from-to)1613-1625
Number of pages13
JournalGastroenterology
Volume125
Issue number6
DOIs
Publication statusPublished - 2003 Dec
Externally publishedYes

Fingerprint

Antimicrobial Cationic Peptides
Helicobacter pylori
Stomach
Epithelial Cells
Gastric Mucosa
Epithelium
Colony-Forming Units Assay
Defensins
Messenger RNA
Pylorus
Infection
In Situ Hybridization
Lipopolysaccharides
Real-Time Polymerase Chain Reaction
Up-Regulation
Inflammation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Expression of LL-37 by Human Gastric Epithelial Cells as a Potential Host Defense Mechanism Against Helicobacter pylori. / Hase, Kouji; Murakami, Masamoto; Iimura, Mitsutoshi; Cole, Sheri P.; Horibe, Yoshimune; Ohtake, Takaaki; Obonyo, Marygorret; Gallo, Richard L.; Eckmann, Lars; Kagnoff, Martin F.

In: Gastroenterology, Vol. 125, No. 6, 12.2003, p. 1613-1625.

Research output: Contribution to journalArticle

Hase, K, Murakami, M, Iimura, M, Cole, SP, Horibe, Y, Ohtake, T, Obonyo, M, Gallo, RL, Eckmann, L & Kagnoff, MF 2003, 'Expression of LL-37 by Human Gastric Epithelial Cells as a Potential Host Defense Mechanism Against Helicobacter pylori', Gastroenterology, vol. 125, no. 6, pp. 1613-1625. https://doi.org/10.1053/j.gastro.2003.08.028
Hase, Kouji ; Murakami, Masamoto ; Iimura, Mitsutoshi ; Cole, Sheri P. ; Horibe, Yoshimune ; Ohtake, Takaaki ; Obonyo, Marygorret ; Gallo, Richard L. ; Eckmann, Lars ; Kagnoff, Martin F. / Expression of LL-37 by Human Gastric Epithelial Cells as a Potential Host Defense Mechanism Against Helicobacter pylori. In: Gastroenterology. 2003 ; Vol. 125, No. 6. pp. 1613-1625.
@article{6ae178df7f8d4d90802bc7f9182e10b1,
title = "Expression of LL-37 by Human Gastric Epithelial Cells as a Potential Host Defense Mechanism Against Helicobacter pylori",
abstract = "Background & Aims: LL-37/human cationic antimicrobial peptide 18 (hCAP18) is a human cathelicidin with broad-spectrum antimicrobial, lipopolysaccharide binding, and chemotactic activities. This study examined the role of LL-37/hCAP18 in gastric innate immune defense by characterizing its constitutive and regulated expression by human gastric mucosa and its bactericidal activity against the gastric pathogen Helicobacter pylori. Methods: LL-37/hCAP18 messenger RNA expression in normal and H. pylori-infected gastric mucosa and gastric epithelial cells was determined by in situ hybridization, real-time polymerase chain reaction, immunostaining, and immunoblot analysis. Bactericidal activity was measured by using a colony-forming unit assay. Results: LL-37/hCAP18 messenger RNA and protein were expressed in a distinct distribution by surface epithelial cells as well as chief and parietal cells in the fundic glands of normal gastric mucosa. LL-37/hCAP18 was significantly increased in the epithelium and gastric secretions of H. pylori-infected patients, but not in individuals with non-H. pylori-induced gastric inflammation. Infection of cultured gastric epithelial cells with a wild-type but not an isogenic ΔcagE mutant strain of H. pylori increased LL-37/hCAP18 expression, indicating that H. pylori-induced regulation of LL-37/hCAP18 production required an intact type IV secretion system. LL-37, the C-terminal peptide of LL-37/hCAP18, alone or in synergy with human β-defensin 1, was bactericidal for several H. pylori strains. Conclusions: These data indicate that H. pylori up-regulates production of LL-37/hCAP18 by gastric epithelium and suggest this cathelicidin contributes to determining the balance between host mucosal defense and H. pylori survival mechanisms that govern chronic infection with this gastric pathogen.",
author = "Kouji Hase and Masamoto Murakami and Mitsutoshi Iimura and Cole, {Sheri P.} and Yoshimune Horibe and Takaaki Ohtake and Marygorret Obonyo and Gallo, {Richard L.} and Lars Eckmann and Kagnoff, {Martin F.}",
year = "2003",
month = "12",
doi = "10.1053/j.gastro.2003.08.028",
language = "English",
volume = "125",
pages = "1613--1625",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Expression of LL-37 by Human Gastric Epithelial Cells as a Potential Host Defense Mechanism Against Helicobacter pylori

AU - Hase, Kouji

AU - Murakami, Masamoto

AU - Iimura, Mitsutoshi

AU - Cole, Sheri P.

AU - Horibe, Yoshimune

AU - Ohtake, Takaaki

AU - Obonyo, Marygorret

AU - Gallo, Richard L.

AU - Eckmann, Lars

AU - Kagnoff, Martin F.

PY - 2003/12

Y1 - 2003/12

N2 - Background & Aims: LL-37/human cationic antimicrobial peptide 18 (hCAP18) is a human cathelicidin with broad-spectrum antimicrobial, lipopolysaccharide binding, and chemotactic activities. This study examined the role of LL-37/hCAP18 in gastric innate immune defense by characterizing its constitutive and regulated expression by human gastric mucosa and its bactericidal activity against the gastric pathogen Helicobacter pylori. Methods: LL-37/hCAP18 messenger RNA expression in normal and H. pylori-infected gastric mucosa and gastric epithelial cells was determined by in situ hybridization, real-time polymerase chain reaction, immunostaining, and immunoblot analysis. Bactericidal activity was measured by using a colony-forming unit assay. Results: LL-37/hCAP18 messenger RNA and protein were expressed in a distinct distribution by surface epithelial cells as well as chief and parietal cells in the fundic glands of normal gastric mucosa. LL-37/hCAP18 was significantly increased in the epithelium and gastric secretions of H. pylori-infected patients, but not in individuals with non-H. pylori-induced gastric inflammation. Infection of cultured gastric epithelial cells with a wild-type but not an isogenic ΔcagE mutant strain of H. pylori increased LL-37/hCAP18 expression, indicating that H. pylori-induced regulation of LL-37/hCAP18 production required an intact type IV secretion system. LL-37, the C-terminal peptide of LL-37/hCAP18, alone or in synergy with human β-defensin 1, was bactericidal for several H. pylori strains. Conclusions: These data indicate that H. pylori up-regulates production of LL-37/hCAP18 by gastric epithelium and suggest this cathelicidin contributes to determining the balance between host mucosal defense and H. pylori survival mechanisms that govern chronic infection with this gastric pathogen.

AB - Background & Aims: LL-37/human cationic antimicrobial peptide 18 (hCAP18) is a human cathelicidin with broad-spectrum antimicrobial, lipopolysaccharide binding, and chemotactic activities. This study examined the role of LL-37/hCAP18 in gastric innate immune defense by characterizing its constitutive and regulated expression by human gastric mucosa and its bactericidal activity against the gastric pathogen Helicobacter pylori. Methods: LL-37/hCAP18 messenger RNA expression in normal and H. pylori-infected gastric mucosa and gastric epithelial cells was determined by in situ hybridization, real-time polymerase chain reaction, immunostaining, and immunoblot analysis. Bactericidal activity was measured by using a colony-forming unit assay. Results: LL-37/hCAP18 messenger RNA and protein were expressed in a distinct distribution by surface epithelial cells as well as chief and parietal cells in the fundic glands of normal gastric mucosa. LL-37/hCAP18 was significantly increased in the epithelium and gastric secretions of H. pylori-infected patients, but not in individuals with non-H. pylori-induced gastric inflammation. Infection of cultured gastric epithelial cells with a wild-type but not an isogenic ΔcagE mutant strain of H. pylori increased LL-37/hCAP18 expression, indicating that H. pylori-induced regulation of LL-37/hCAP18 production required an intact type IV secretion system. LL-37, the C-terminal peptide of LL-37/hCAP18, alone or in synergy with human β-defensin 1, was bactericidal for several H. pylori strains. Conclusions: These data indicate that H. pylori up-regulates production of LL-37/hCAP18 by gastric epithelium and suggest this cathelicidin contributes to determining the balance between host mucosal defense and H. pylori survival mechanisms that govern chronic infection with this gastric pathogen.

UR - http://www.scopus.com/inward/record.url?scp=10744224946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744224946&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2003.08.028

DO - 10.1053/j.gastro.2003.08.028

M3 - Article

VL - 125

SP - 1613

EP - 1625

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 6

ER -